Zacks Investment Research on MSN
OraSure files for FDA review of molecular self-test & Colli-Pee device
OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at ...
Chlamydia trachomatis is one of the most common sexually transmitted infections (STIs). Chlamydia can lead to serious complications if untreated. It can be hard to know if you have chlamydia since it ...
Are you searching for effective medications to treat 'Chlamydia Trachomatis'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...
Chlamydia trachomatis is an obligate intracellular bacterium and a major cause of sexually transmitted bacterial infections worldwide. Chlamydial infections are typically asymptomatic and reinfections ...
Chlamydia trachomatis remains a major global pathogen causing both ocular and genital infections, contributing significantly to public health burdens such as infertility, pelvic inflammatory disease, ...
The complications are few and are quite rare, but when they occur they usually are as follows: 1. Pelvic inflammatory disease (PID), which is a serious infection of the reproductive organs in women.
Chlamydia is a prevalent sexually transmitted infection. World Health Organisation reports millions of new STI cases annually. Chlamydia trachomatis is a common cause. Many infected individuals show ...
Chlamydia trachomatis infections are a global health problem. This obligate intracellular bacterial pathogen comprises lymphogranuloma venereum (L1–L3), ocular (A–C) and genital (D–K) serovars.
After infection, Chlamydia (blue) replicate in a large vesicle inside the cell. Because most cases of this common bacterial infection are asymptomatic, regular screening of at-risk patients is key to ...
A mini model of the human intestines suggests that chlamydia bacteria can colonize the gut, potentially contributing to recurrent infections. When you purchase through links on our site, we may earn ...
Technologies submitted two separate applications at the end of 2025 to the U.S. Food and Drug Administration for clearance of its ...
There are a number of C. trachomatis gene products that exhibit variability and may modulate disease severity (Figure 3). The major categories of variable chlamydial gene products and their roles in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results